Evidence map›Paper›PMID 29332716›Full record

ArticleJournal of the American Academy of Dermatology2018

Predicting the incidence and timing of central nervous system disease in metastatic melanoma: Implications for surveillance and preventative therapy.

Gary B Deutsch, Richard Tyrell, Samuel Yost, Mariel B Deutsch, Garni Barkhoudarian, Daniel F Kelly, Mark B Faries

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Academy of Dermatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Gary B DeutschHofstra-Northwell School of Medicine Uniondale, New York, New York. Electronic address: gdeutsch@northwell.edu.
Richard TyrellHofstra-Northwell School of Medicine Uniondale, New York, New York.
Samuel YostBrain Tumor Center, New York, New York.
Mariel B DeutschDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York.
Garni BarkhoudarianBrain Tumor Center, New York, New York.
Daniel F KellyBrain Tumor Center, New York, New York.
Mark B FariesDonald L. Morton, MD, Melanoma Research Program, New York, New York.
Children's Brain Tumor Foundation · USHofstra University · USIcahn School of Medicine at Mount Sinai · US

Funding

Multicenter Selective Lymphadenectomy Trial (MSLT II) in MelanomaR01CA189163 · NCI · SAINT JOHN'S CANCER INSTITUTE · PI FARIES, MARK B · 2014 to 2018
$8.1M
NCI NIH HHS R01 CA189163
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Population SurveillanceAntineoplastic Agents, ImmunologicalBrain NeoplasmsDisease-Free SurvivalExtremitiesFemaleHumansIpilimumabMaleMelanomaRisk FactorsSex FactorsSkin NeoplasmsSkin UlcerSurvival RateAntineoplastic Agents, ImmunologicalIpilimumab

Identifiers

PMID29332716
PMCPMC5783312
OpenAlexW2784022064

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.